Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yost

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Blood|May 26, 2021
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effectsKristina Maas-Bauer, Juliane K Lohmeyer, Toshihito Hirai, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case studyYuan Yuan, Colt Egelston, Oscar Colunga Flores, et al.
Cell|May 8, 2018
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary ElementSeung Woo Cho, Jin Xu, Ruping Sun, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Cell|June 24, 2022
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceJulia A Belk, Winnie Yao, Nghi Ly, et al.
Immunity|July 23, 2024
Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiationFrank A Buquicchio, Raissa Fonseca, Patrick K Yan, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Blood|May 26, 2021
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effectsKristina Maas-Bauer, Juliane K Lohmeyer, Toshihito Hirai, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case studyYuan Yuan, Colt Egelston, Oscar Colunga Flores, et al.
Cell|May 8, 2018
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary ElementSeung Woo Cho, Jin Xu, Ruping Sun, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Cell|June 24, 2022
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceJulia A Belk, Winnie Yao, Nghi Ly, et al.
Immunity|July 23, 2024
Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiationFrank A Buquicchio, Raissa Fonseca, Patrick K Yan, et al.
Pageof 14